본문 바로가기

Immune and Tumor Microenvironment Mechanisms of Hedyotis diffusa Willd: A Scoping Review and Network Pharmacology Analysis

문서 유형
연구출판물 · 리뷰논문
등재
SCIEScopus
저널 순위
JCR Q2Scopus Q1
저널
CANCERS18(4) · 2026
피인용
Web of Science 1Scopus 1
FWCI (Scopus)
0.91
JCR IF
JCR 2024 4.4
ISSN
2072-6694

저자

  1. Kim, Soo-Dam제1저자Korea Inst Oriental Med, KM Sci Res Div, Daejeon 34054, South Korea
  2. Park, Eun SooDaejeon Univ, Daejeon Korean Med Hosp, East West Canc Ctr, Daejeon 34520, South Korea
  3. Park, Jung HyangDaejeon Univ, Daejeon Korean Med Hosp, East West Canc Ctr, Daejeon 34520, South Korea
  4. Yeo, Tae-KyungOculi Korean Med Hosp, Seoul 05655, South Korea
  5. 김동현Pusan Natl Univ, Korean Med Hosp, Yangsan 50612, South Korea
  6. 박소정교신저자Pusan Natl Univ, Korean Med Hosp, Yangsan 50612, South Korea
  7. Yoo, Hwa-Seung교신저자Daejeon Univ, Daejeon Korean Med Hosp, East West Canc Ctr, Daejeon 34520, South Korea

초록

Background: The tumor microenvironment (TME) is a dynamic ecosystem that critically shapes tumor progression, immune escape, and therapeutic responses. Hedyotis diffusa Willd (HDW) has long been used in East Asian medicine for conditions associated with inflammation and malignancy, yet its immunological and microenvironmental mechanisms have not been systematically synthesized. Methods: A scoping review of preclinical studies (2016–2025) was conducted following the Arksey-O’Malley framework and PRISMA-ScR guidance to systematically map experimental evidence on the antitumor, immune-related, and TME-associated effects of HDW. To complement and interpret these heterogeneous experimental findings at a systems level, a network pharmacology analysis was performed to identify bioactive compounds, predict their putative protein targets, and assess their convergence on immune- and microenvironment-related signaling networks through protein-protein interaction and pathway enrichment analyses. Results: Fifty-nine studies met eligibility criteria, encompassing in vitro and in vivo models across diverse cancer types. Experimental evidence from preclinical models showed that HDW extracts and bioactive fractions consistently suppressed proliferation, induced apoptosis and ferroptosis, inhibited epithelial-mesenchymal transition (EMT) and angiogenesis, and enhanced cytotoxic lymphocyte activity, while attenuating tumor-associated inflammation. In parallel, in silico network analysis identified 94 intersecting immune- and TME-related targets and revealed a densely connected interaction network centered on PI3K-Akt, STAT3, EGFR, and SRC. Enrichment analyses highlighted receptor tyrosine kinase signaling, inflammatory pathways, metabolic regulation, and focal adhesion as dominant functional themes. Conclusions: HDW acts as a multi-target botanical agent that integrates direct cytotoxicity with immune activation and TME remodeling. Network-in-formed interpretation indicates that the modulation of PI3K-Akt-STAT3 signaling is a common mechanistic axis linking experimental observations.

키워드

Hedyotis diffusa Willdherbal medicineimmunomodulationnetwork pharmacologytumor microenvironment

식별자

Scopus EID
2-s2.0-105031406301
WoS UID
001699971800001